312 Efficacy and Safety of ASP7147, a Bombesin-2 Receptor Antagonist, in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): Results of a Multicenter, Double-Blind, Placebo-Controlled Trial
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 107
(11)
◽
pp. 1702-1712
◽
Keyword(s):
2014 ◽
Vol 109
◽
pp. S541
◽
Keyword(s):
2020 ◽
Vol 26
(1)
◽
pp. 117-127
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 106
◽
pp. S501
Keyword(s):